📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Lytic activity against primary AML cells is stimulated in vitro by an autologous whole cell vaccine expressing IL-2 and CD80. (2010)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00262-009-0756-x

PubMed Identifier: 19711075

Publication URI: http://europepmc.org/abstract/MED/19711075

Type: Journal Article/Review

Volume: 59

Parent Publication: Cancer immunology, immunotherapy : CII

Issue: 3

ISSN: 0340-7004